A. Muftah

Clinical utility of reverse phase protein array for molecular classification of breast cancer

Patrick J Tighe, Ian O Ellis, I. Ellis, 2015, Breast Cancer Research and Treatment.

Immunohistochemical Characterization of the Inflammatory Responses in Wound Healing and the Use of the Subcutaneous Polyvinyl Alcohol (PVA) Sponge Implantation for Evaluation of the Healing Process

E. Jude, A. Muftah, S. A. El-Aleem, 2018 .

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response

I. Ellis, E. Rakha, A. Green, 2015, British Journal of Cancer.

ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer

I. Ellis, A. Green, E. Rakha, 2014, Breast Cancer Research and Treatment.

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections

I. Ellis, C. Caldas, A. Green, 2017, Breast Cancer Research and Treatment.

The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways

I. Ellis, A. Green, E. Rakha, 2015, Breast Cancer Research and Treatment.

Molecular-Based Diagnostic, Prognostic and Predictive Tests in Breast Cancer

I. Ellis, E. Rakha, M. Aleskandarany, 2015 .

Further evidence to support bimodality of oestrogen receptor expression in breast cancer

I. Ellis, C. Caldas, A. Green, 2017, Histopathology.

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes

A. Green, E. Rakha, M. Toss, 2020, Breast Cancer Research and Treatment.

Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer

I. Ellis, Simak Ali, A. Mukherjee, 2015, Breast Cancer Research and Treatment.

THE CLINICAL AND BIOLOGICAL SIGNIFICANCE OF ESTROGEN RECEPTOR-LOW POSITIVE BREAST CANCER.

A. Green, E. Rakha, N. Mongan, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.